Patients with BAV, the most common cardiac congenital anomaly, are more susceptible to ascending aortic dilation compared with patients with normal tricuspid aortic valves. 20 We compared the ACE2 levels in the ascending aorta and activity by Western blot analysis ( Figure 1A ), fluorescencebased activity assay ( Figure 1B) , and immunofluorescence ( Figure 1C ; Figure S1 in the online-only Data Supplement). Dilated thoracic aorta obtained from patients with BAV (n=4 men; age 49±3.2 years) showed marked upregulation of ACE2 compared with the aorta from nondiseased controls (n=4 men; age=43±4.1 years; Figure 1A -1C). Consistent with this clinical finding, Ang II infusion for 2 and 4 weeks in wild-type (WT) mice exhibited a substantial increase in aortic ACE2 expression and activity by Western blotting ( Figure 1D ), fluorescence-based activity assay ( Figure 1E ), and immunofluorescence ( Figure 1F ) compared with WT control aortas. We hypothesize that upregulation of ACE2 was compensatory and suppresses the activation of the RAS and hence plays a crucial role in protecting against vascular disease. Histological analysis using Movat pentachrome and Gomori trichrome staining of ACE2 knockout (KO) mesenteric resistance arteries (MA) showed marked lumen dilation with loss of vascular wall thickness, resulting in decreased media-to-lumen ratio in response to 2 weeks of Ang II infusion ( Figure 1G and 1H). However, there was equivalent perivascular fibrosis in the WT and ACE2KO MAs in response to Ang II infusion (Figure 1G and 1H; Figure S2A ). Ex vivo passive vascular properties of WT and ACE2KO receiving Ang II for 2 weeks showed increased vascular stiffness in ACE2KO MA ( Figure 1I and IJ). With aging, vascular stiffness also increased in the 6-month-old ACE2KO MA compared with WT ( Figure 1K ), whereas no basal difference was found in the MA stiffness between young WT and ACE2KO mice ( Figure S2B ). Ang II infusion for 2 weeks in the WT mice did not exhibit a significant change in the MA stiffness compared with WT control MA ( Figure  S2C ). These results show that ACE2 is upregulated in human and murine diseased aorta, whereas loss of ACE2 resulted in greater adverse vascular remodeling in response to Ang II.
Loss of ACE2 Potentiates Vascular Oxidative Stress and VSMC Apoptosis: Role of the AT1R and Ang 1 to 7
Ang II is a well-known stimulant of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase system and induces production of ROS in the vascular cells. 1, 21, 22 Ang II resulted in greater activation of the NADPH oxidase system (Figure 2A ), as well as greater immunoreactivity for nitrotyrosine ( Figure 2B ), a marker for peroxynitrite formation, in the ACE2KO MA compared with WT MA. Dihydroethidium staining showed markedly increased ROS production in ACE2KO aortic VSMCs ( Figure 2C ; Figure S3A and S3B) and an increased NADPH oxidase activity in response to Ang II stimulation ( Figure 2D ). AT1R blockade using irbesartan and Ang 1 to 7 supplementation was equally effective in suppressing the elevated oxidative stress in ACE2KO VSMCs in response to Ang II (Figure 2C-2E ; Figure S3A and S3B). Apoptosis represents a dominant mode of VSMC loss, leading to adverse vascular remodeling. [23] [24] [25] Terminal deoxynucleotidyltransferase-mediated 2'-deoxyuridine-5'-triphosphate nick-end labeling (TUNEL) staining in the MA shows increased apoptosis of VSMCs in ACE2KO MA in response to Ang II ( Figure 2E ; Figure S4 ), which correlated with reduced VSMC density as determined by calponin that is a specific marker of VSMCs and wheat germ agglutinin double staining ( Figure 2F-2H) , as well as immunofluorescence staining for α-smooth muscle actin ( Figure 2I ).
To provide definitive evidence for this, we isolated aortic VSMCs from WT and ACE2KO mice and treated them with equal concentration of Ang II (100 nmol/L). Calponin and vimentin double immunostaining confirmed that our preparation was composed mostly of VSMCs ( Figure S5 ). The annexin V-fluorescein isothiocyanate/propidium iodide staining followed by flow cytometric analysis revealed markedly increased apoptosis in ACE2KO aortic VSMCs in response to Ang II (Figure 3A and 3B; Figure S6A ). We next performed TUNEL assay along with calponin staining in aortas exposed to Ang II to assess VSMC-specific apoptosis. TUNEL assay revealed a marked increase in VSMC apoptosis in Ang IItreated ACE2KO mice ( Figure 3C ; Figure S6B ). TUNELpositive cells were also detected in the adventitia in the Ang II-treated ACE2KO mice ( Figure 3C ). Ang II resulted in a greater increase in cleaved caspase-3, as well as cleaved caspase-8 levels, with no change in the caspase-3 levels in the ACE2KO aorta compared with WT aortas ( Figure 3D ; Figure  S6C ), consistent with increased apoptosis in the ACE2KO-Ang II aortas. Matrix metalloproteinases (MMPs) are known to play a crucial role in adverse vascular remodeling. [26] [27] [28] Ang II resulted in a greater increase in pro-MMP2, as well as MMP2 and MMP9 protein levels, in ACE2KO compared with the WT aortas ( Figure 3E ). Importantly, in situ gelatin zymography showed increased MMP activity within the ACE2KO aorta in response to Ang II, confirming that the increased MMP2 and MMP9 proteins are concordant with increased MMP activity ( Figure 3F ). Clearly, loss of ACE2 increased the production of ROS and apoptotic loss of VSMCs, leading to progression of adverse vascular remodeling, a process suppressible by antagonizing the AT1R or enhancing Ang 1 to 7 action.
Loss of ACE2 Potentiates Adverse Aortic Remodeling in Response to Ang II
The role of ACE2 in the progression of adverse vascular remodeling in resistance arteries implies a critical role of ACE2 in disease progression in the major conductance artery, the aorta. Ang II administration resulted in greater activation of NADPH oxidase ( Figure 4A ) along with greater immunoreactivity for nitrotyrosine ( Figure 4B ) in ACE2KO aorta compared with WT aortas. Ultrastructural analysis with transmission electron microscopy exhibited worsened structural damage in the aorta from ACE2KO mice in response to Ang II compared with the WT mice characterized by disruption of the inner elastic membrane and disarranged smooth muscle layer with swollen mitochondria ( Figure 4C ; Figure S7 ). Next, we examined the long-term outcome of these effects. Four weeks of Ang II infusion resulted in greater aortic dilation in ACE2KO mice based on gross morphometry ( Figure 4D ) and ultrasonic imaging ( Figure 4E ). The aortic systolic expansion index, a measure of aortic elasticity and recoil properties during systole and diastole, 29 was significantly suppressed in the Ang II-infused ACE2KO mice in the thoracic ( Figure 4F-4H ) and abdominal showing luminal dilation and thinning of media in ACE2KO vessels along with equivalent fibrosis in response to Ang II (G) with positive remodeling seen in the wild-type (WT) arteries leading to thickening of the media, mild luminal dilation, and increased media-to-lumen ratio (H). Ex vivo passive pressure myography showing pressure-dependent changes in lumen diameter of MA after 2 weeks of Ang II infusion in young WT and ACE2KO mice (I and J), and in 6-month-old WT and ACE2KO mice (K) revealed greater vascular stiffness compared with the WT. MemCode reversible protein staining was used as loading control for the Western blot analysis. *P<0.05 compared with the corresponding control group (B and C; F and G; J-K); #P<0.05 for the main effects and $P<0.05 for the interaction using 2-way ANOVA (I). R.E. indicates relative expression; and R.R., relative ratio. 30, 31 Gomori trichrome staining and calponin immunofluorescence images (along with elastin autofluorescence) revealed a marked increase in aortic medial thickness in WT compared with ACE2KO mice (Figure 4I-4K) . Next, we performed calponin and wheat germ agglutinin double staining to assess the VSMC density, which revealed that WT thoracic aorta showed a marked increase in medial VSMCs which was lacking in the ACE2KO thoracic aorta in response to 4 weeks of Ang II infusion (Figure 4J and 4K; Figure S9 ). Thus, loss of ACE2 increased adverse vascular remodeling in the aorta in response to Ang II resulting in loss of VSMCs and aortic dilation, a prelude to the formation of aortic aneurysms.
Discussion
The RAS plays a central role in the pathophysiology of several vascular diseases, and the suppression of the ACE/Ang II/ AT1R axis has important clinical benefits.
2,3,32,33 ACE2/Ang 1 to 7/Mas receptor is the counter-regulatory axis of the RAS where ACE2 serves as an endogenous negative regulator of the RAS. We found upregulation of ACE2 in dilated ascending human aorta in patients with BAV, as well as in mice aorta, in response to Ang II infusion that highlights a concordant relationship between aortic ACE2 protein levels and activity in both human and murine aortic disease. We predicted these changes to be compensatory and sought to study the role of ACE2 in Ang II-induced adverse vascular remodeling. We used the Ang II infusion model of adverse vascular remodeling, which is an accepted preclinical model of aortic aneurysm in dyslipidemic mice. 3, 34, 35 We found greater vascular stiffness with the ex vivo passive characteristics of MA vessels in ACE2KO mice in response to Ang II, which is likely because of the loss of VSMCs. Importantly, these mice showed senile changes in vascular function, resulting in increased vascular stiffness. Adverse vascular remodeling in conductance arteries from ACE2KO mice was exacerbated in response to Ang II. These changes in the ACE2KO vessels were associated with decreased smooth muscle cell density in the media and correlate with increased sensitivity to age 36 and Ang IIdependent hypertension. 9 In the absence of ACE2, blocking the AT1 receptor or enhancing Ang 1 to 7 action had therapeutic effects, illustrating an active contribution from both arms of the RAS.
Histopathologic changes in human aortic aneurysms predominantly affect the medial layer that is normally dominated by elastic fibers and VSMCs. VSMCs maintain vascular tone mainly through coordinated contraction/relaxation and also play a key role in arterial wall remodeling through proliferation, hypertrophy, and apoptosis. 19, 24 The modulation of VSMC phenotypic changes is an early event of adverse vascular remodeling, often leading to aortic dilation and aneurysm. 31 We showed greater increase in NADPH oxidase-dependent ROS production and secondary nitrotyrosine formation and increased VSMC apoptosis in Ang II-infused ACE2KO mice aorta associated with increased cleaved caspase-3/caspase-8 levels. Importantly, ROS mediates protein kinase C-mediated VSMC apoptosis, 37 and the role of ROS has been implicated in the formation of aortic aneurysms because inhibition of ROS generation attenuated aneurysm formation. 4, 38, 39 Our results are consistent with previous findings linking ACE2 deficiency to increased Ang II-mediated ROS production, NADPH oxidase activity and nitrotyrosine levels in the aorta, 40, 41 and increased Ang II levels in the vasculature. 18 Ang II-induced VSMC proliferation is seen with short-term exposure to Ang II in WT VSMCs. 17, 41, 42 In our study, Ang II infusion to WT mice leads to increased media-to-lumen ratio in both the MA and aorta, implying increased media thickness (possibly because of increased VSMC proliferation or hypertrophy). However, Ang II exposure in the ACE2KO background increased VSMC apoptosis, highlighting a critical role of ACE2 in the inhibition of VSMC apoptosis. This correlates with the phenotype-dependent effects of Ang II on the VSMCs. 23 A phenotype-dependent effect of Ang II on VSMCs is characterized by a lack of Ang II effect on cell survival of the spindle VSMCs, whereas delayed Ang II exposure is proapoptotic in the epithelioid VSMCs. 23 Importantly, despite the increased apoptosis in the ACE2KO VSMCs, the media thickness and the VSMC density did not decrease compared with the saline infused aorta. This suggests that, unlike in the WT vessels, Ang II-induced cellular proliferation is counterbalanced by increased apoptosis in the ACE2KO vessels. TUNEL staining in the Ang II-infused ACE2KO aorta showed increased apoptosis of not only the VSMCs but also the non-VSMC cell types present in the adventitia. However, further work is needed to determine which adventitial cell types are undergoing apoptosis and their possible role in vascular disease in the ACE2KO mice.
Loss of ACE2 resulted in increased MMP2 and MMP9 levels and increased MMP activity within the aortic wall in response to Ang II. MMPs contribute to the extracellular matrix turnover by degrading existing proteins, 28, 34 and increased activated MMP2 and MMP9 levels in patients with aortic aneurysms degrade the vascular extracellular matrix, leading to aortic dilation. 43 Importantly, increased MMP2 activity coexists with VSMC apoptosis in the aorta from patients with Marfan syndrome, as well as BAV. 44 In summary, our results provide a link between Ang II-induced ROS production, MMP activation, and VSMC apoptosis with the potential counter-regulatory role of ACE2 in adverse vascular remodeling. The pathophysiological significance of this constellation of molecular, biochemical, and structural changes in ACE2-deficient vasculature is further strengthened by the well-established link between ACE2 deficiency and the promotion of an atherosclerotic phenotype. [16] [17] [18] Collectively, these results strongly implicate the ACE2 pathway as a critical mediator of vascular disease. Enhancing ACE2 action may have therapeutic benefits in vascular diseases.
Perspectives
BAV is the most common congenital cardiac abnormality, occurring in 1% of the population. Patients with BAV have increased risk (and at a younger age) of ascending aortic dilatation than it does in patients with normal trileaflet aortic valves. Aortic dilatation has a propensity for dissection and rupture, making it a potentially lethal disease. RAS regulates vascular tone and plays a key role in adaptive and maladaptive vascular remodeling. ACE2 is a newly discovered member of RAS family, which converts Ang II into a vasculoprotective peptide Ang 1 to 7). We found upregulation of ACE2 in the aorta from patients with BAV. We also found ACE2 upregulation in the Ang II-infused mice aorta. Ang II infusion is a widely accepted clinically relevant preclinical model of RAS activation. Ang II infusion in ACE2KO mice resulted in increased adverse vascular remodeling, showing marked aortic dilation that was associated with increased VSMC apoptosis. These data are in agreement with the histological features of aortic aneurysm. Histopathologic changes in human aortic aneurysms predominantly affect the medial layer that is normally dominated by elastic fibers and VSMCs. The modulation of VSMC phenotypic changes including VSMC apoptosis is an early event of adverse vascular remodeling, often leading to aortic dilation and aneurysm. Our data suggest that ACE2 is a key negative regulator of activated RAS-driven adverse vascular remodeling, and enhancing ACE2 could have beneficial effects in vascular diseases.
What Is New?
• Loss of angiotensin-converting enzyme 2 (ACE2) exacerbates adverse vascular remodeling.
• ACE2 negatively regulates angiotensin II-induced vascular smooth muscle cell apoptosis and vascular oxidative stress.
What Is Relevant?
• Loss of ACE2 sensitizes the vasculature to angiotensin II-mediated adverse remodeling, leading to increased vascular stiffness.
• Angiotensin II type 1 receptor blockade and angiotensin 1 to 7 are protective in ACE2-deficient vascular smooth muscle cells.
Summary
Angiotensin II-induced vascular smooth muscle cell apoptosis and oxidative stress are enhanced in the ACE2KO vasculature, leading to adverse vascular remodeling and vascular dilation. Department of Physiology, 6 Department of Obstetrics and Gynecology, University of Alberta, Edmonton, Canada.
Supplemental Methods

Experimental animals and protocols. Ace2
-/y mutant mice that were backcrossed into the C57BL/6 background for at least 8 generations were used in the present study. [1] [2] [3] [4] As Ace2 is an X-linked gene, Ace2 -/y represents ACE2 null of ACE2 knockout mice. Mice were housed in pathogen-free conditions and had access to sterilized food and water ad libitium. All experiments were performed in accordance to institutional guidelines, Canadian Council on Animal Care and the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Alzet micro-osmotic pumps (Model 1002, Durect Corp.) were implanted subcutaneously in male mice of the indicated genotypes to deliver 1.5 mg/kg/day Ang II or saline (control) for 2 or 4 wk. 1, 5 Human aortic specimen. Ascending aorta from patients with bicuspid aortic valve (BAV) and aortopathy undergoing aortic valve replacement and ascending repair at the Mazankowski Alberta Heart Institute. Non-diseased controls were collected as part of the Human Organ Procurement and Exchange (HOPE) program for research. All experiments were performed in accordance with the institutional guidelines and were approved by Institutional Ethics Committee.
Ex vivo vascular passive characteristics. Second-order mesenteric arteries were used from the mice to study the ex vivo vascular passive characteristics as previously described. 6, 7 Second-2 order mesenteric arteries were used from the mice to study the ex vivo vascular passive characteristics as previously described. 7 Briefly, tissue dissections were performed in ice-cold physiological saline solution (PSS), composition (in mmol/L): 10 HEPES, 5.5 glucose, 1.56 CaCl2, 4.7 KCl, 142 NaCl, 1.17 MgSO4, 1.18 KH2PO4, pH 7.5. Arteries were cleaned of all surrounding adipose and connective tissues and mounted on two glass cannulae in a two-bath pressure myograph (Living Systems, Burlington, VT). Vessels were given a 40-minute equilibration period during which they were exposed to a stepwise increase in pressure from 60 to 80 mmHg with regular changes of the PSS bathing solution. Vessels were equilibrated in Ca2+-free PSS in the presence of papaverine (0.1 μmol/L) to initiate complete dilation. Passive characteristics were then assessed using pressures from 0 to 140 mmHg. Ex vivo analysis of circumferential wall stress and wall strain (change in diameter/original diameter) mesenteric arteries were calculated as previously described.
6
Ultrasonic imaging of aorta. Ultrasonic images of the aorta were obtained in mice anesthetized with isoflurane using a Vevo 770 high resolution imaging system equipped with a real time microvisualization scan head (RMV 704, Visual Sonics, Toronto, Canada). 5 The aortic diameters were measured by M-mode at thoracic aorta and abdominal aorta The maximum aortic lumen diameter (aortic systolic diameter corresponding to cardiac systole) and the minimum aortic lumen diameter (aortic diastolic diameter corresponding to cardiac diastole) monitored by simultaneous ECG recordings were measured and used to calculate the aortic expansion index [(Systolic aortic diameter -Diastolic aortic diameter)/Systolic diameter X 100].
Isolation and culture of Vascular Smooth Muscle Cells. Vascular smooth muscle cells (VSMCs)
were isolated from 8-to 10-wk old WT and ACE2KO mice aortas and cultured as described previously. 8 Briefly, thoracic and abdominal aortas were obtained from 8-to 10-weeks-old mice. The adventitial and inner layers of aorta were dissected off. The aortic media were cut into small pieces and attached to the surface of 35 mm dishes by drying for 15 minutes. The explants were cultured in DMEM (Gibco) containing 10% fetal bovine serum (FBS, Sigma) supplemented with 50 µg/mL gentamicin (Gibco) at 5% CO 2 incubator. Cells migrated from the explants and were passaged when they reached 100% confluency. The purity of the VSMCs was examined with smooth muscle-specific calponin and mesenchymal cell marker, vimentin, double immunostaining. VSMCs were serum-deprived for 24 hours by incubation in DMEM with 0.1% BSA and gentamicin and then treated with or without 1 mM hydrogen peroxide in DMEM+0.1% BSA as a positive control for apoptotic analysis. Vascular smooth muscle cells were treated with 100 nM Ang II in DMEM+0.1% BSA for 24 hours and were used between passages 4 and 5. Irbesartan (1 μM) and Ang 1-7 (Bachem, Germany; 100 nM) were added to the VSMCs for 30 min prior to exposure of Ang II.
Histological analyses, Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, Wheat germ agglutinin staining and immunofluorescence. Mice were perfuse-fixed at 80 mmHg with paraformaldehyde after 2 wk of Ang II or saline infusion allowing the blood vessels to be fixed in its native state as previously described. 7 Subsequently, mesenteric arteries were dissected out, carefully not to alter the structure of the vessels, further fixed in 10% 3 buffered formalin for 48 hr and paraffin-embedded. Aorta were collected and fixed in 10% buffered formalin for 48 hr from the mice infused with Ang II or saline for 2 and 4 wk. In separate experiments, aortas were collected and fixed in OCT for cryosections. Five µm thick formalin fixed paraffin embedded (FFPE) sections were used for the histological staining including Movat's pentachrome and Gomori Trichrome as previously described. 5, 7 Collagenpositive area in the MA was quantified by the morphometric analysis using the Metamorph Basic (version 7.7.0.0) software. It was represented as the normalized ratio to the vessel crosssectional area. In situ DNA fragmentation was detected in 5 µm thick FFPE sections of mesenteric arteries and aorta using the commercially available terminal deoxynucleotidyltransferase-mediated dUTP nick-end labeling (TUNEL) assay kit according to manufacturer's instructions (Invitrogen) as previously described. 4, 9 Five µm thick FFPE sections were used for the immunofluorescence staining for ACE2, alpha-smooth muscle actin, calponin, and nitrotyrosine immunofluorescence as well as wheat germ agglutinin staining as previously described.
2, 9, 10 Elastin autofluorescence was used to assess the media thickness in the aorta. Briefly, media thickness was assessed in the calibrated images by measuring the mean distance between the external elastic lamina and the internal elastic lamina from 8 different regions in the cross-section of aorta usning the Metamorph Basic (version 7.7.0.0). [11] [12] [13] Calponin positive cells in the aorta delineated with WGA cell membrane staining were imaged using Confocal microscope (SP5, Leica) and counted to assess the VSMC density at the brightest focal plane using Fiji/ImageJ v1.48q. Paraformaldehyde fixed VSMCs were double stained for calponin and vimentin to assess the purity of the VSMC culture. Briefly, the VSMCs were stained with rabbit anti-calponin (Abcam) and rabbit anti-vimentin (Abcam) primary antibodies and Alexa Fluor 488 conjugated anti-rabbit and Alexa Fluor 594 conjugated anti-mouse secondary antibodies. The cells were imaged using the fluorescence microscope (Olympus IX81) and analyzed using the Fiji/ImageJ v1.48q.
In situ gelatin zymography. In situ gelatin zymography was performed on 14 μm thick aorta cryosections as described previously. 5 Briefly, aorta cryosections were incubated with 0.1% agarose containing DQ-gelatin (Invitrogen) at 37°C for 1 hour and then imaged using fluorescence microscope (Olympus IX81) using GFP filter. Autofluorescence was captured using Texas red filter to show the elastin fibers.
Transmission Electron Microscope analysis. For transmission electron microscope analysis, samples of mice aorta tissues were fixed in 2.5% glutaraldehyde and then washed three times with phosphate buffered saline, followed by postfixation with 1% osmium tetroxide for 1 h, stained with 2% aqueous uranyl acetate, and dehydrated in a graded series of ethanol. After infiltration and polymerization, ultrathin sections were cut, flattened with xylene vapor, collected on nickel grids, and observed on a HITACHI-600 electron microscope (Hitachi, Japan) with magnification 2500x and 7400x.
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity assay and dihydroethidium staining. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity in mesenteric arteries, aorta as well as aortic VSMCs was quantified by lucigeninenhanced chemiluminescence using a single-tube luminometer (Berthold FB12, Berthold showing decreased vascular smooth cell density in the ACE2KO aorta in response to Ang II infusion. In the fluorescence images, green color represents wheat germ agglutinin stained cell membranes, red color represents calponin and blue color represents DAPI stained nuclei. # p<0.05 for the interaction using twoway ANOVA.
